Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
23.29
+0.37 (1.61%)
Oct 8, 2025, 9:54 AM EDT - Market open
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $675.60 million as of October 8, 2025. Its market cap has decreased by -22.60% in one year.
Market Cap
675.60M
Enterprise Value
426.29M
1-Year Change
-22.60%
Ranking
Category
Stock Price
$23.29
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $675.60M, an increase of 449.04%. That is a compound annual growth rate of 31.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 664.87M | -10.92% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | 1.62B | 176.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |